Showing results (231-240 of 445) with videos related to
Sort By:
Pageof 45
Journal of the American Heart Association|April 29, 2023
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD TrialGlenn M Chertow, Ricardo Correa-Rotter, Priya Vart, et al.Nephrology (Carlton, Vic.)|August 24, 2020
Perspectives on blood pressure by patients on haemo- and peritoneal dialysisNicole Evangelidis, Benedicte Sautenet, Karine E Manera, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 2023
Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trialHiddo J L Heerspink, Peter J Greasley, Christine Ahlström, et al.Kidney International|October 31, 2020
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancerCamillo Porta, Aristotelis Bamias, Farhad R Danesh, et al.Diabetes, Obesity & Metabolism|June 16, 2026
Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study)William Hinton, Mark Joy, Anna K Forbes, et al.Journal of Nephrology|March 30, 2023
Predictors of quality of life in patients within the first year of commencing haemodialysis based on baseline data from the PIVOTAL trial and associations with the study outcomesSunil Bhandari, Patrick Parfrey, Claire White, et al.Clinical Journal of the American Society of Nephrology : CJASN|November 29, 2015
Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on DialysisPatrick S Parfrey, Geoffrey A Block, Ricardo Correa-Rotter, et al.Kidney International|December 5, 2020
KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantationJolanta Małyszko, Aristotelis Bamias, Farhad R Danesh, et al.The New England Journal of Medicine|October 27, 2018
Intravenous Iron in Patients Undergoing Maintenance HemodialysisIain C Macdougall, Claire White, Stefan D Anker, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 5, 2024
SGLT2 Inhibitors - The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative ReviewSamuel Seidu, Vicki Alabraba, Sarah Davies, et al.Pageof 45